These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1143 related articles for article (PubMed ID: 2249337)

  • 1. Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma. Experience of the French Study Group.
    Avril MF; Bonneterre J; Delaunay M; Grosshans E; Fumoleua P; Israel L; Bugat R; Namer M; Cupissol D; Kerbrat P
    Cancer Chemother Pharmacol; 1990; 27(2):81-4. PubMed ID: 2249337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fotemustine plus dacarbazine for malignant melanoma.
    Avril MF; Bonneterre J; Cupissol D; Grob JJ; Kalis B; Fumoleau P; Kerbrat P; Israel L; Fargeot P; Lambert D
    Eur J Cancer; 1992; 28A(11):1807-11. PubMed ID: 1389514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination of fotemustine-dacarbazine and interferon alpha in the treatment of metastatic malignant melanoma].
    Célérier P; Dreno B; Bureau B; Litoux P
    Ann Dermatol Venereol; 1993; 120(6-7):437-40. PubMed ID: 8279787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of the sequential administration of dacarbazine and fotemustine in the treatment of cerebral metastases from malignant melanoma.
    Chang J; Atkinson H; A'Hern R; Lorentzos A; Gore ME
    Eur J Cancer; 1994; 30A(14):2093-5. PubMed ID: 7857710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patients.
    Rixe O; Borel C; Paraiso D; Benhammouda A; Petit T; Antoine E; Bizzari JP; Auclerc G; Soubrane C; Weil M
    Melanoma Res; 1995 Dec; 5(6):419-24. PubMed ID: 8589616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fotemustine plus dacarbazine in advanced stage III malignant melanoma.
    Binder M; Winkler A; Dorffner R; Glebowski E; Wolff K; Pehamberger H
    Eur J Cancer; 1992; 28A(11):1814-6. PubMed ID: 1389516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fotemustine and DTIC combination in patients with disseminated malignant melanoma.
    Merimsky O; Inbar M; Chaitchik S
    Am J Clin Oncol; 1992 Feb; 15(1):84-6. PubMed ID: 1550085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with dacarbazine, cisplatin, fotemustine and tamoxifen in metastatic malignant melanoma.
    Richard MA; Grob JJ; Zarrour H; Bassères N; Bizzari JP; Gérard B; Bonerandi JJ
    Melanoma Res; 1998 Apr; 8(2):170-4. PubMed ID: 9610872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases.
    Jacquillat C; Khayat D; Banzet P; Weil M; Fumoleau P; Avril MF; Namer M; Bonneterre J; Kerbrat P; Bonerandi JJ
    Cancer; 1990 Nov; 66(9):1873-8. PubMed ID: 2224783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine.
    Seeber A; Binder M; Steiner A; Wolff K; Pehamberger H
    Eur J Cancer; 1998 Dec; 34(13):2129-31. PubMed ID: 10070323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fotemustine and interferon alpha2b in metastatic malignant melanoma.
    Weichenthal M; Mohr P; Stephan U; Altenhoff J; Kowalzick L; Marseille A; Sarkany M; Hossfeld DK; Breitbart EW
    J Cancer Res Clin Oncol; 1998 Jan; 124(1):55-9. PubMed ID: 9498836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide in combination with fotemustine in patients with metastatic melanoma.
    Tas F; Camlica H; Topuz E
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):293-8. PubMed ID: 17909803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term complete remissions in patients with disseminated melanoma treated by fotemustine and dacarbazine.
    Oliver V; Aliaga A; Lopez Lopez JJ; Perez E; Ponchon A; Bizzari JP; Cour V
    Eur J Cancer; 1993; 29A(2):287. PubMed ID: 8422299
    [No Abstract]   [Full Text] [Related]  

  • 14. Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.
    Di Giacomo AM; Ascierto PA; Pilla L; Santinami M; Ferrucci PF; Giannarelli D; Marasco A; Rivoltini L; Simeone E; Nicoletti SV; Fonsatti E; Annesi D; Queirolo P; Testori A; Ridolfi R; Parmiani G; Maio M
    Lancet Oncol; 2012 Sep; 13(9):879-86. PubMed ID: 22894884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment of stage IV melanoma patients with amifostine and fotemustine--a pilot study.
    Mohr P; Makki A; Breitbart E; Schadendorf D
    Melanoma Res; 1998 Apr; 8(2):166-9. PubMed ID: 9610871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fotemustine: an overview of its clinical activity in disseminated malignant melanoma.
    Khayat D; Avril MF; Gerard B; Bertrand P; Bizzari JP; Cour V
    Melanoma Res; 1992 Sep; 2(3):147-51. PubMed ID: 1450667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
    Daponte A; Ascierto PA; Gravina A; Melucci MT; Palmieri G; Comella P; Cellerino R; DeLena M; Marini G; Comella G;
    Cancer; 2000 Dec; 89(12):2630-6. PubMed ID: 11135225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity and unexpected lung toxicity of the sequential administration of two alkylating agents--dacarbazine and fotemustine--in patients with melanoma.
    Gerard B; Aamdal S; Lee SM; Leyvraz S; Lucas C; D'Incalci M; Bizzari JP
    Eur J Cancer; 1993; 29A(5):711-9. PubMed ID: 8471329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanoma.
    Jacquillat C; Khayat D; Banzet P; Weil M; Avril MF; Fumoleau P; Namer M; Bonneterre J; Kerbrat P; Bonerandi JJ
    Cancer Chemother Pharmacol; 1990; 25(4):263-6. PubMed ID: 2403853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fotemustine--an advance in the treatment of metastatic malignant melanoma.
    Merimsky O; Inbar M; Gerard B; Chaitchik S
    Melanoma Res; 1992 Dec; 2(5-6):401-6. PubMed ID: 1292787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.